List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 97 studies with search of: "Idarubicin"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Trial of PXD101 in Combination With Idarubicin to Treat Acute Myeloid Leukemia (AML) Not Suitable for Standard Intensive Therapy
Condition: Acute Myeloid Leukemia
Interventions: Drug: PXD101 + idarubicin;   Drug: PXD101 + idarubicin
2 Recruiting Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006)
Conditions: AML;   Acute Myeloid Leukemia;   Myelodysplastic Disorders
Interventions: Drug: Idarubicin;   Drug: sorafenib;   Drug: Ara-C
3 Recruiting Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)
Conditions: Leukemia;   Acute Myeloid Leukemia;   AML
Interventions: Drug: Cytarabine;   Drug: Idarubicin
4 Recruiting Phase II Study of Idarubicin, Cytarabine, and Vorinostat in Patients With High-Risk MDS and AML
Conditions: Acute Myeloid Leukemia (AML);   Myelodysplastic Syndrome (MDS)
Interventions: Drug: Idarubicin;   Drug: Cytarabine;   Drug: Vorinostat
5 Active, not recruiting Phase I Using Velcade & Idarubicin in Elderly and Relapsed AML
Condition: Acute Myelogenous Leukemia
Interventions: Drug: Velcade;   Drug: Idarubicin
6 Recruiting Clofarabine Combinations in Relapsed/Refractory AML, MDS and Myeloid Blast Phase CML
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndrome;   Chronic Myeloid Leukemia
Interventions: Drug: Clofarabine;   Drug: Idarubicin;   Drug: Ara-C
7 Recruiting Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: thalidomide;   Drug: idarubicin
8 Recruiting Study of Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)
Conditions: Myelodysplastic Syndrome;   Acute Myeloid Leukemia
Interventions: Drug: Idarubicin;   Drug: Cytarabine;   Drug: lenalidomide
9 Active, not recruiting Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma
Condition: Primary Central Nervous System Lymphoma
Interventions: Drug: Idarubicin, Methotrexate, Filgrastim, intrathecal Ara-C;   Radiation: Radiation Therapy
10 Not yet recruiting Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: idarubicin;   Drug: pravastatin
11 Recruiting Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: idarubicin
12 Recruiting Salvage Therapy With Idarubicin in Relapsing CNS Lymphoma
Condition: Lymphoma, B-Cell
Intervention: Drug: Idarubicin
13 Completed Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Biological: bevacizumab;   Drug: cytarabine;   Drug: idarubicin
14 Active, not recruiting Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: busulfan;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: gemtuzumab ozogamicin;   Drug: idarubicin;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
15 Suspended Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: idarubicin;   Drug: vorinostat;   Genetic: microarray analysis;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: biopsy
16 Active, not recruiting Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: cytarabine;   Drug: idarubicin;   Drug: tipifarnib
17 Active, not recruiting VELCADE in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous Leukemia
Condition: Leukemia
Interventions: Drug: velcade;   Drug: Idarubicin;   Drug: Cytarabine
18 Completed Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia
Condition: Leukemia
Interventions: Biological: bevacizumab;   Drug: cytarabine;   Drug: idarubicin
19 Active, not recruiting Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: idarubicin;   Drug: pravastatin
20 Active, not recruiting Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Biological: filgrastim;   Drug: arsenic trioxide;   Drug: cytarabine;   Drug: idarubicin

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services